-
From the Editor-in-Chief
Inheritance, ‘Bad Luck’ and the EnvironmentWhy do some people develop cancer while others do not?
by William G. Nelson, MD, PhD
-
Forward Look
There Goes the NeighborhoodQ&A with scientist Zena Werb on cancer, immunity and the microenvironment.
by Chris Palmer
-
Forward Look
Cost of Breast Cancer Treatment Affects AdherenceDrug for early-stage cancer must be taken for many years to be effective.
by Kendall K. Morgan
-
Forward Look
Cancer Treatment Can Reactivate Hepatitis BResearchers make the case for screening cancer patients for hepatitis B before treatment.
by Yasmine Iqbal
-
Forward Look
First Biosimilar Drug Approved in U.S.New drugs will offer same effectiveness, but at a lower cost.
by Stephen Ornes
-
-
The DCIS DilemmaDuctal carcinoma in situ is the fourth most common cancer diagnosis in women. Some say it's not "really" cancer. But you wouldn't know that based on how it is treated.
by Sue Rochman
-
Healthy Habits
Reaping the BenefitsFollowing a vegetarian diet could reduce your risk of colorectal cancer.
by Leigh Labrie
-
From the Editor-in-Chief
The Promise of Precision MedicineThe impact of gene sequencing on the discovery and development of cancer treatments could be profound.
by William G. Nelson, MD, PhD
-
Forward Look
Genetic Testing Can Help Women With Triple-Negative Breast CancerStudy confirms inherited genetic mutations are common, regardless of family history.
by Kendall K. Morgan
Despite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood TestsAbout half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
-
Cancer in the Rearview Mirror: 15 Years of AACR Cancer Progress Report Survivor StoriesCancer survivors profiled over the past 15 years in the AACR Cancer Progress Reports shared updates on their lives and the progress made against cancer.
-
Pediatric Cancer’s AftershocksNew research highlights approaches that could provide better long-term quality of life for childhood cancer survivors.
Cancer Research at a Crossroads
